THZ-0104

N/A

Report date: 2026/02/27 20:01:47

Base Information

Drug NameTHZ-0104
Drug Alias NameTHZ0104THZ-0104
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-Programmed death-ligand 1Anti-Lymphocyte activation gene 3 protein
TargetsProgrammed death-ligand 1Lymphocyte activation gene 3 protein
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesTJ Biopharma(Hangzhou) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesTJ Biopharma(Hangzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A